Geriatric Medicine Doctors in Evanston, IL - Medicare Status, Address, Contact

1 Geriatric Medicine doctors found. Showing 1 - 1

Peter Loren Jaggard, MD
Internal Medicine - Geriatric Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 3200 Grant St, Evanston, IL 60201
Phone: 847-492-4828 Fax: 847-492-4810

News Archive

Scientists identify 'hidden' driver that helps prime the anti-tumor immune response

Like exposing a crime boss whose authority has gone undetected, St. Jude Children's Research Hospital scientists have identified a hidden driver that influences production of the T cells that fight cancer and infections. The study appears today as an advance online publication in the journal Nature.

Preschool children in rural areas eat more fruits and vegetables when the produce is homegrown

If you are looking for a way to encourage your children eat their fruits and vegetables, search no further than your backyard, suggests new Saint Louis University research.

Researchers identify new mechanism in onset of motor neuron diseases

The British astrophysicist Stephen Hawking is likely to be the world's most famous person living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ALS is a progressive disease affecting motor neurons, nerve cells that control muscle function, and nearly always leads to death.

Research opens door to new direction of PAH treatment

The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.

OXiGENE reports consolidated net loss of $11.0M for first-quarter 2010

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter ended March 31, 2010, and presented an update on recent clinical and corporate progress.

Geriatric Medicine Doctors in Evanston, IL Accepting Medicare